Hence, our observation that IL-10 production was elicited from peptide-stimulated circulating MG-specific CD4+ T cells further supports the notion that re-instating tolerance through stimulation of Tregs could be a way forward for treatment of MG disease. Here, CD4 is linked to myasthenia gravis.